Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Inamura K. Lung cancer: understanding its molecular pathology and the 2015 WHO Classification. Front Oncol. 2017;7:193.
   PubMed Web of Science ®Google Scholar
• Tanoue LT. Lung Cancer Staging. Clin Chest Med. 2020;41(2):161–174.
   PubMed Web of Science ®Google Scholar
• Basumallik N, Agarwal M. Small cell lung cancer. StatPearls. Treasure Island (FL). 2021.
   Google Scholar
• Rodriguez M, Ajona D, Seijo LM, et al. Molecular biomarkers in early stage lung cancer. Transl Lung Cancer Res. 2021;10(2):1165–1185.
   PubMed Web of Science ®Google Scholar
• Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond). 2018;18:s41–s6.
   PubMed Web of Science ®Google Scholar
• Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288–300.
   PubMed Web of Science ®Google Scholar
• Hsu M, Wang Y, Tseng Y. Exosomal proteins and lipids as potential biomarkers for lung cancer diagnosis, prognosis, and treatment. Cancers (Basel). 2022;14(3):732.
   PubMed Web of Science ®Google Scholar
• Sexauer D, Gray E, Zaenker P. Tumour- associated autoantibodies as prognostic cancer biomarkers- a review. Autoimmun Rev. 2022;21(4):103041.
   PubMed Web of Science ®Google Scholar
• Saller J, Boyle T. Molecular pathology of lung cancer. Cold Spring Harb Perspect Med. 2022;12(3):a037812.
   PubMed Web of Science ®Google Scholar
• Swamynathan SK. Kruppel-like factors: three fingers in control. Hum Genomics. 2010;4(4):263–270.
   PubMedGoogle Scholar
• Yao W, Jiao Y, Zhou Y, et al. KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis. Cell Biosci. 2020;10(1):76.
   PubMed Web of Science ®Google Scholar
• Xin Y, Su P, Liu Y, et al. Knock out hepatic Krüppel-like factor 16 (KLF16) improve myocardial damage and promoted myocardial protection of myocardial ischemia-reperfusion via anti-oxidative and anti-inflammation effects by TFAM/PPARβ signal passage. Bioengineered. 2021;12(2):10219–10231.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu W, Wang X, et al. KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer. Onco Targets Ther. 2020;13:1303–10.
   Google Scholar
• Bang S, Li J, Zhang M, et al. The Clinical Relevance and Function of Krüppel-Like Factor 16 in Breast Cancer. Cancer Manag Res. 2020;12:6373–83.
   Google Scholar
• Ma P, Sun C, Wang Y, et al. KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4. Am J Transl Res. 2017;9:1307–37.
   Google Scholar
• Fernandez-Zapico ME, Lomberk GA, Tsuji S, et al. A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS -mediated cell growth. Biochem J. 2011;435(2):529–537.
   PubMedGoogle Scholar
• Weinberger P, Ponny S, Xu H, et al. Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma. Thyroid. 2017;27(2):236–252.
   Google Scholar
• Ye L, Liu R, Lin P, et al. Krüppel-like transcription factor 16 transcriptional up-regulation of cellular retinoic acid-binding proteins-2 promotes the invasion and migration and inhibits apoptosis of retinoblastoma cells by regulating integrin-β1/focal adhesion kinase /extracellular signal-regulated kinase pathway. Bioengineered. 2022;13:3694–3706.
   PubMed Web of Science ®Google Scholar
• Bang S, Li J, Zhang M, et al. The clinical relevance and function of krüppel-like factor 16 in breast cancer. Cancer Manag Res. 2020;12:6373–6383.
   PubMed Web of Science ®Google Scholar
• Wu W, Jia L, Zhang Y, et al. Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genes. Bioengineered. 2021;12(1):7417–7431.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zheng Q, Wang C, et al. CCDC106 promotes non-small cell lung cancer cell proliferation. Oncotarget. 2017;8(16):26662–26670.
   PubMedGoogle Scholar
• Gan H, Xu X, Bai Y. Trametes robiniophila represses angiogenesis and tumor growth of lung cancer via strengthening let-7d-5p and targeting NAP1L1. Bioengineered. 2022;13(3):6698–6710.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yan P, Wang J, et al. Clinical significance of tumor miR-21, miR-221, miR-143, and miR-106a as biomarkers in patients with osteosarcoma. Int J Biol Markers. 2019;34(2):184–193.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Tang X, Ding H, Liang M, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12(8):1219–1230.
   PubMed Web of Science ®Google Scholar
• Ku J, Hong S, Kim H, et al. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Phytomedicine. 2020;66:153109.
   PubMed Web of Science ®Google Scholar
• Gao W, Liu Y, Qin R, et al. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line. Biochem Biophys Res Commun. 2016;476(1):35–41.
   PubMed Web of Science ®Google Scholar
• Duan H, Lei Z, Xu F, et al. PARK2 suppresses proliferation and tumorigenicity in non-small cell lung cancer. Front Oncol. 2019;9:790.
   PubMed Web of Science ®Google Scholar
• Mfotie Njoya E, Eloff J, McGaw L. Croton gratissimus leaf extracts inhibit cancer cell growth by inducing caspase 3/7 activation with additional anti-inflammatory and antioxidant activities. BMC Complement Altern Med. 2018;18(1):305.
   PubMedGoogle Scholar
• Marquardt N, Feja M, Hunigen H, et al. Euthanasia of laboratory mice: are isoflurane and sevoflurane real alternatives to carbon dioxide? PLoS One. 2018;13(9):e0203793.
   PubMed Web of Science ®Google Scholar
• Xie P, Tang Y, Shen S, et al. Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells. Biochem Biophys Res Commun. 2011;407(1):254–259.
   PubMed Web of Science ®Google Scholar
• Wei MC, Wang YM, Wang DW. miR-130a-Mediated KLF3 Can Inhibit the Growth of Lung Cancer Cells. Cancer Manag Res. 2021;13:2995–3004.
   Google Scholar
• Wang X, Xia S, Li H, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020; 27:1747–64.
   Google Scholar
• Li K, Yuan C. MicroRNA–103 modulates tumor progression by targeting KLF7 in non–small cell lung cancer. Int J Mol Med. 2020; 46:1013–28.
   Google Scholar
• Zhao M, Ma W, Ma C. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway. Biomed Pharmacother. 2020; 129:110461.
   Google Scholar
• Fang QY, Deng QF, Luo J, et al. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9. Eur Rev Med Pharmacol Sci. 2020; 24:2548–56.
   Google Scholar
• Son B, Jeon J, Lee S, et al. Radiotherapy in combination with hyperthermia suppresses lung cancer progression via increased NR4A3 and KLF11 expression. Int J Radiat Biol. 2019;95(12):1696–1707.
   PubMed Web of Science ®Google Scholar
• Ali A, Bhatti MZ, Shah AS, et al. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer. J Biol Chem. 2015; 290:21336–51.
   Google Scholar
• Biamonti G, Giacca M, Perini G, et al. The gene for a novel human lamin maps at a highly transcribed locus of chromosome 19 which replicates at the onset of S-phase. Mol Cell Biol. 1992;12(8):3499–3506.
   PubMed Web of Science ®Google Scholar
• Dechat T, Pfleghaar K, Sengupta K, et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 2008;22(7):832–853.
   PubMed Web of Science ®Google Scholar
• Shimi T, Pfleghaar K, Kojima S, et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev. 2008;22(24):3409–3421.
   PubMed Web of Science ®Google Scholar
• Deng W, Yan M, Yu T, et al. Quantitative proteomic analysis of the metastasis-inhibitory mechanism of miR-193a-3p in non-small cell lung cancer. Cell Physiol Biochem. 2015;35(5):1677–1688.
   PubMedGoogle Scholar
• Ma Y, Fei L, Zhang M, et al. Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis. Oncotarget. 2017; 8:104813–30.
   Google Scholar